Paradigm Shift in Liver & Pancreatic Cancer

Paradigm Shift in Liver & Pancreatic Cancer

A clearer look at how cancer research is evolving today, from the behaviour of liver and pancreatic tumours to the technologies influencing modern treatment. This session explains the key shifts in oncology, showing how emerging therapies and microenvironment insights are opening possibilities for earlier intervention, better outcomes and more personalised care. It is ideal for anyone seeking to understand where cancer science is heading and why these developments matter for the future of healthcare.

SPEAKER:

Assoc. Prof. Dr. Glenn Kunnath Bonney

Director of Research, Department of Surgery, National University Hospital (NUH)

Director and Principal Investigator, SurgiCAL ProtEomics Laboratory (SCALPEL), iHealthtech, National University of Singapore

Dr Glenn Kunnath Bonney brings core expertise in tumour biology, liver immunology and the cancer microenvironment. He is recognised for his extensive publications, scientific presentations and invited lectures in liver transplantation, hepatocellular carcinoma, colorectal liver metastasis and pancreatic cancer, and continues to contribute actively to translational oncology and gastrointestinal cancer therapeutics.